Candida parapsilosis: from Genes to the Bedside

Patients with suppressed immunity are at the highest risk for hospital-acquired infections. Among these, invasive candidiasis is the most prevalent systemic fungal nosocomial infection. Over recent decades, the combined prevalence of non- species outranked infections in several geographical regions...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical microbiology reviews 2019-03, Vol.32 (2)
Hauptverfasser:	Tóth, Renáta, Nosek, Jozef, Mora-Montes, Héctor M, Gabaldon, Toni, Bliss, Joseph M, Nosanchuk, Joshua D, Turner, Siobhán A, Butler, Geraldine, Vágvölgyi, Csaba, Gácser, Attila
Format:	Artikel
Sprache:	eng
Schlagworte:	Antifungal Agents - pharmacology Antifungal Agents - therapeutic use Candida parapsilosis - drug effects Candida parapsilosis - genetics Candida parapsilosis - pathogenicity Candidiasis - drug therapy Candidiasis - epidemiology Cross Infection - drug therapy Cross Infection - epidemiology Cross Infection - microbiology Gene Expression Profiling Humans Incidence Microbial Sensitivity Tests Review Sequence Analysis, DNA Sequence Analysis, RNA
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!